{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Spinal+and+Bulbar+Muscular+Atrophy+%28SBMA%29&page=2", "query": { "condition": "Spinal and Bulbar Muscular Atrophy (SBMA)", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 140, "total_pages": 14, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Spinal+and+Bulbar+Muscular+Atrophy+%28SBMA%29&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Spinal+and+Bulbar+Muscular+Atrophy+%28SBMA%29&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-05T04:05:45.998Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06592924", "title": "Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostate Cancer (Adenocarcinoma)" ], "interventions": [ { "name": "Abiraterone", "type": "DRUG" }, { "name": "Enzalutamide", "type": "DRUG" }, { "name": "Apalutamide", "type": "DRUG" }, { "name": "Darolutamide (BAY 1841788)", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" }, { "name": "ADT", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Canadian Cancer Trials Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 830, "start_date": "2025-05-28", "completion_date": "2031-04-15", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-10-05T04:05:45.998Z", "location_count": 374, "location_summary": "Anchorage, Alaska • Fairbanks, Alaska • Phoenix, Arizona + 272 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT06592924" }, { "nct_id": "NCT01251861", "title": "Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Prostate Carcinoma", "Stage I Prostate Cancer AJCC v7", "Stage IIA Prostate Cancer AJCC v7", "Stage IIB Prostate Cancer AJCC v7", "Stage III Prostate Cancer AJCC v7" ], "interventions": [ { "name": "Akt Inhibitor MK2206", "type": "DRUG" }, { "name": "Bicalutamide", "type": "DRUG" }, { "name": "Clinical Observation", "type": "OTHER" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 108, "start_date": "2011-03-17", "completion_date": "2026-05-26", "has_results": true, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-10-05T04:05:45.998Z", "location_count": 192, "location_summary": "Palo Alto, California • Aurora, Colorado • Boulder, Colorado + 139 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01251861" }, { "nct_id": "NCT02749903", "title": "Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Salivary Cancer" ], "interventions": [ { "name": "enzalutamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2016-09-14", "completion_date": "2028-07-05", "has_results": true, "last_update_posted_date": "2026-02-11", "last_synced_at": "2026-10-05T04:05:45.998Z", "location_count": 287, "location_summary": "Anchorage, Alaska • Anaheim, California • Baldwin Park, California + 201 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT02749903" }, { "nct_id": "NCT04090528", "title": "pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Castration-resistant Prostate Cancer", "Metastatic Cancer", "Prostate Cancer" ], "interventions": [ { "name": "pTVG-HP", "type": "BIOLOGICAL" }, { "name": "pTVG-AR", "type": "BIOLOGICAL" }, { "name": "Pembrolizumab", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 60, "start_date": "2019-10-21", "completion_date": "2027-03", "has_results": true, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-10-05T04:05:45.998Z", "location_count": 2, "location_summary": "St Louis, Missouri • Madison, Wisconsin", "locations": [ { "city": "St Louis", "state": "Missouri" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04090528" }, { "nct_id": "NCT00878436", "title": "Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Prostate Cancer", "Prostatic Neoplasms" ], "interventions": [ { "name": "Panobinostat", "type": "DRUG" }, { "name": "Bicalutamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 52, "start_date": "2009-06", "completion_date": "2015-07", "has_results": true, "last_update_posted_date": "2018-02-07", "last_synced_at": "2026-10-05T04:05:45.998Z", "location_count": 4, "location_summary": "New Brunswick, New Jersey • Lake Success, New York • New York, New York + 1 more", "locations": [ { "city": "New Brunswick", "state": "New Jersey" }, { "city": "Lake Success", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00878436" }, { "nct_id": "NCT06204302", "title": "An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Non-metastatic Prostate Cancer", "Non-metastatic Castration-resistant Prostate Cancer" ], "interventions": [ { "name": "Darolutamide (Nubeqa, BAY1841788)", "type": "DRUG" }, { "name": "Enzalutamide", "type": "DRUG" }, { "name": "Apalutamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 1800, "start_date": "2024-01-05", "completion_date": "2024-04-04", "has_results": false, "last_update_posted_date": "2024-04-09", "last_synced_at": "2026-10-05T04:05:45.998Z", "location_count": 1, "location_summary": "Whippany, New Jersey", "locations": [ { "city": "Whippany", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT06204302" }, { "nct_id": "NCT02124057", "title": "Study of Hepatic Function in Patients With Spinal and Bulbar Muscular Atrophy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Spinal and Bulbar Muscular Atrophy (SBMA)", "Motor Neuron Disease" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 71, "start_date": "2014-08-04", "completion_date": "2020-11-19", "has_results": false, "last_update_posted_date": "2022-08-18", "last_synced_at": "2026-10-05T04:05:45.998Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02124057" }, { "nct_id": "NCT03296124", "title": "Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32)", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Prostate Cancer" ], "interventions": [], "intervention_types": [], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 0, "start_date": "2017-12-07", "completion_date": "2020-09", "has_results": false, "last_update_posted_date": "2018-11-16", "last_synced_at": "2026-10-05T04:05:45.998Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03296124" }, { "nct_id": "NCT05517603", "title": "A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Spinal and Bulbar Muscular Atrophy", "Kennedy's Disease" ], "interventions": [ { "name": "AJ201", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AnnJi Pharmaceutical Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 25, "start_date": "2023-02-28", "completion_date": "2024-04-08", "has_results": false, "last_update_posted_date": "2024-08-15", "last_synced_at": "2026-10-05T04:05:45.998Z", "location_count": 6, "location_summary": "Orange, California • Palo Alto, California • Jacksonville, Florida + 3 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05517603" }, { "nct_id": "NCT07832292", "title": "A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostatic Neoplasms" ], "interventions": [ { "name": "JNJ-101556143", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 100, "start_date": "2026-09-16", "completion_date": "2030-05-20", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-05T04:05:45.998Z", "location_count": 4, "location_summary": "Lafayette, Louisiana • Plymouth, Massachusetts • Syracuse, New York + 1 more", "locations": [ { "city": "Lafayette", "state": "Louisiana" }, { "city": "Plymouth", "state": "Massachusetts" }, { "city": "Syracuse", "state": "New York" }, { "city": "Germantown", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT07832292" } ] }